Announcements Trials
Browse Landscape

Status

Available 3Approved for marketing 2

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 198Observational 20Expanded_access 5

Sponsor

Cancer Type

Plasma cell 10Lymphoid 10Other hematologic neoplasm 5CNS 5Endocrine 2Thoracic 1Sarcoma 1Other neoplasm 1Myeloid 1Head & Neck 1Genitourinary 1Gastrointestinal 1

Conditions

Glioblastoma 15Neuroblastoma 13Glioma 11Pheochromocytoma 7Neoplasms 6Recurrence 5Paraganglioma 5Pancreatic Neoplasms 3Melanoma 3Head and Neck Neoplasms 3Brain Neoplasms 3Stomach Neoplasms 2Ovarian Neoplasms 2Oligodendroglioma 2Neurofibroma, Plexiform 2Neuroectodermal Tumors, Primitive 2Medulloblastoma 2Diffuse Intrinsic Pontine Glioma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Astrocytoma 2Wilms Tumor 1Urinary Bladder Neoplasms 1Typical Teratoid Rhabdoid Tumor 1Thyroid cancer, medullary 1Thyroid Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1

Interventions

3-Iodobenzylguanidine 3vorasidenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Expanded_access × Recurrence × CNS × Clear all
NCT06872489 2025-07-23

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

Second Life Therapeutics

Available
CNSGastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Neuroblastoma, Pancreatic Neoplasms, Recurrence

NCT01370330 2025-07-22

131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol

University of California, San Francisco

Available
CNS

Neoplasms, Neuroblastoma, Recurrence

NCT05592743 2024-11-05

Vorasidenib Expanded Access Program

Servier

Approved for marketing
CNS

Astrocytoma, Glioma, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Glandular and Epithelial, Neoplasms, Nerve Tissue, Oligodendroglioma, Pathologic Processes, Recurrence, Neuroectodermal Tumors, Neoplasms, Neuroepithelial, Disease Attributes

NCT03015844 2024-07-05

A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma

Northwell Health

Available
CNSEndocrine

Neuroblastoma, Pheochromocytoma, Recurrence

NCT01377532 2020-05-06

Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma

University of California, San Francisco

Approved for marketing
CNSEndocrine

Neoplasms, Paraganglioma, Pheochromocytoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡